Health Care & Life Sciences » Pharmaceuticals | Canopy Growth Corp.

Canopy Growth Corp. | Balance Sheet

Fiscal year is April-March. All values CAD Millions.
2015
2016
2017
2018
2019
Cash & Short Term Investments
21
15
102
323
4,536
Total Accounts Receivable
1
1
6
21
107
Inventories
6
27
60
118
341
Other Current Assets
-
1
4
19
86
Total Current Assets
29
45
172
482
5,070
Net Property, Plant & Equipment
18
45
96
304
1,096
Total Investments and Advances
-
-
-
235
476
Intangible Assets
-
53
404
416
2,064
Other Assets
-
1
6
-
26
Total Assets
48
146
706
1,477
8,778
ST Debt & Current Portion LT Debt
-
1
2
2
Accounts Payable
4
6
15
46
Other Current Liabilities
-
1
1
44
Total Current Liabilities
5
7
18
92
Long-Term Debt
2
3
9
7
Deferred Taxes
-
7
36
34
Other Liabilities
-
2
1
61
Total Liabilities
6
22
91
234
Common Equity (Total)
41
124
615
1,159
Total Shareholders' Equity
41
124
615
1,159
Total Equity
41
124
615
1,243
Liabilities & Shareholders' Equity
48
146
706
1,477
Accumulated Minority Interest
-
-
-
84

About Canopy Growth

View Profile
Address
1 Hershey Drive
Smith Falls Ontario K7A 0A8
Canada
Employees -
Website http://www.canopygrowth.com
Updated 07/08/2019
Canopy Growth Corp. engages in the production and sale of medical cannabis. The company offers products including oils and concentrates, soft gel capsules, and hemp. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite.